(earlham.edu): This week's BMJ is dominated by a cluster of articles on oseltamivir (Tamiflu). Between them the articles conclude that the evidence that oseltamivir reduces complications in otherwise healthy people with pandemic influenza is now uncertain and that we need a radical change in the rules on access to trial data.
(publishingperspectives.com): LeWeb, the largest technology conference in Europe, attracted nearly 2,400 attendees from 50 countries. Attendees represented a diversity of companies, from mobile carriers and device makers, to social media networks, small startups, and search providers - but very few from the publishing community. Why is that? Sure, the discussion was largely focused on social media, online marketing, mobile opportunities, and content distribution. Publishers who ignore such tech conferences are missing out on the next wave of innovation - on the very evolution of content creation, distribution and consumption. Companies and people at this conference (and others like it) are shaping the future.
(foodconsumer.org): Effective drug companies' marketing strategies have been convincing health care professionals and the public to change the laws. They can now sell their unproven and unsafe products in pharmacies, airports, college campuses, grocery stores and countless other outlets, despite the fact that three years ago, a study in the British Medical Journal concluded that the effectiveness of annual flu shots has been greatly exaggerated, and that in reality they have little or no effect on influenza campaign objectives. A study published in the Lancet found that influenza vaccination was NOT associated with a reduced risk of pneumonia in older people. That Lancet study supports a similar study done in 2006, published in The New England Journal of Medicine, which concluded that vaccination against pneumonia does not reduce your risk of contracting the disease.
(cmswatch.com): With only a few weeks left in 2009, it's time for the team of CMS Watch analysts to reveal their 2010 predictions, where they make there best guesses as to what the Content Technology industry will hold for you in the new year. On a whole, 2010 will be characterised by a movement by "back to the basics" among technology vendors. This includes a renewed focus on internal content technology applications. While some of these changes may seem modest, oftentimes recessionary times are the catalysts for necessary changes to be made.
(gfii.asso.fr): The GFII Working Group includes representatives from the main economic stakeholders involved in Open Access: research institutes, publishers, aggregators, internet services, subscription agents, academic libraries, etc. This statement summarizes the Group recommendations. The Group would like to first stress the need for a discipline sensitive approach to open access. To be effective, the dissemination of scientific and technological information must be organized on a discipline specific way. A discipline can be defined - among others, by the related scientific community, which can be very multidisciplinary or not, its history, its knowledge base, methods, and time scale, its specific ways of disseminating scientific output, the local or international characteristics of subjects studied, and its methodology.